Novo Nordisk A/S Sponsored BDR (N1VO34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
27. 66
-0.3
-1.073%
R$
970.85B Market Cap
48.26 P/E Ratio
0.32% Div Yield
16,979 Volume
0 Eps
R$ 27.96
Previous Close Want to track N1VO34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S Sponsored BDR (N1VO34) Statistics
Valuation metrics
Market Cap 970.85B
Enterprise value 193.45B
Trailing P/E (ttm) 10.81
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) 3.1
Price/Book (mrq) 0.81
Enterprise Value/Revenue 0.77
Enterprise Value/EBITDA 1.44
Overview
Shares outstanding 4.44B
Float 3.19B
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 42.53K
Average volume (90 days) 30.13K
Price summary
52-Week low 22.9
52-Week high 57.25
Beta 0.35
50-Day moving average 25.01
200-Day moving average 32.96
Dividends and splits
Forward annual dividend rate 1.11
Forward annual dividend yield 0.0386%
Trailing annual dividend rate 0.83
Trailing annual dividend yield 0.029%
5-Year annual dividend yield 1.45%
Payout ratio 0.3
Dividend Date 14 Apr 2026
Ex-Dividend Date 26 Mar 2026
Last split factor 2:1
Last split Date 20 Sep 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.37%
Operating margin 0.62%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.71%
Income Statement
Revenue (ttm) 252.85B
Revenue per share (ttm) 73.77
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 210.36B
EBITDA 181.54B
Net income to common (ttm) 94.07B
Diluted EPS (ttm) 2.65
Quarterly earnings growth (yoy) 0.67%
Balance Sheet
Total cash (mrq) 16.68B
Total cash per share (mrq) 4.87
Total debt (mrq) 112.91B
Total Debt/Equity (mrq) 72.09
Current ratio (mrq) 0.79%
Book value per share (mrq) 35.38
Cash Flow
Cash flow statement 91.37B
Levered free cash flow (LFCF) -9.29B
